SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-030277
Filing Date
2022-11-03
Accepted
2022-11-03 07:05:25
Documents
14
Period of Report
2022-11-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 46051
2 ex99-1.htm EX-99.1 325597
3 ex99-1_001.jpg GRAPHIC 3121
  Complete submission text file 0001493152-22-030277.txt   570544

Data Files

Seq Description Document Type Size
4 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xtnt-20221103.xsd EX-101.SCH 3239
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xtnt-20221103_lab.xml EX-101.LAB 34916
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xtnt-20221103_pre.xml EX-101.PRE 22797
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3664
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

IRS No.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34951 | Film No.: 221356148
SIC: 2836 Biological Products, (No Diagnostic Substances)